Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, 7SL, cytoplasmic 225, pseudogene (RN7SL225P) is annotated as a pseudogene related to the 7SL RNA family, originally involved in the signal recognition particle (SRP) complex that facilitates cotranslational targeting of proteins to the endoplasmic reticulum membrane[1][3][6][7]. As a pseudogene, RN7SL225P is a non-coding genomic sequence homologous to functional 7SL RNA genes but generally does not encode a functional RNA product and is not implicated in canonical biological pathways or as a therapeutic target[6][7]. There are no known drug interactions, mechanisms of action, or direct disease roles assigned to this locus, and no recognized utility as a biomarker or safety concern. As a pseudogene, it is not considered a therapeutic target and there are no established biological or medical functions for RN7SL225P specifically. Notes: - RN7SL pseudogenes are numerous in the human genome and display various truncated or altered structures resembling 7SL RNA[7]. Their annotation can sometimes be confused with the functional SRP 7SL RNA, but the "pseudogene" designation means they are not functional targets[6][7]. - If you are seeking actionable therapeutic, biomarker, or druggability information, this entry is not a relevant target. - If you are seeking information on the functional SRP RNA, search for "RNA, 7SL, cytoplasmic 1 (RN7SL1)" or "Signal recognition particle RNA."[1][3]
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, 7SL, cytoplasmic 225, pseudogene (RN7SL225P).